Substituted 2, 4-imidazolidinedione compounds as pharmaceutical

Details Substituted 2, 4-imidazolidinedione compounds as pharmaceutical Substituted 2, 4-imidazolidinedione compounds as pharmaceutical

1996-10-25

1999-12-21

Dees, Jose' G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514363, 514365, 514336, 514374, 514378, 514397, 514341, 544359, 544366, 548147, 548137, 548196, 548240, 5462681, 5462684, 5462727, C07D40300, C07D41704, A61K 3141, A61K 31425

Patent

active

060049634

ABSTRACT:
A substituted 2,4-imidazolidinedione compound corresponding to the formula I ##STR1## a process for production thereof and the use of these compounds in a pharmaceutical preparation are described. Substituents R1, R2, R3 and R4 have the same meaning as defined in the specification.

REFERENCES:
patent: 4746669 (1988-05-01), Caldwell et al.
patent: 4944791 (1990-07-01), Schroder et al.
Peng et al., "Potential Central Nervous System Antitumor Agents, Hydantoin Derivatives", Journal of Medicinal Chemistry, 1975, vol. 18, No. 8, pp. 846-849.
Oldfield et al., "The Chemistry and Pharmacology of a Series of Cycloalkanespiro-5'-hydantoins", J. Med. Chem., vol. 8, pp. 239-249 (1965).
Clauss et al., "Modulation of Endothelial Cell Hemostatic Properties by TNF: Insights Into the Role of Endothelium in the Host Response to Inflammatory Stimuli", Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine, edited by Bruce Beutler, Raven Press, Ltd., New York, pp. 49-63, (1992).
Satsangi et al., "1-(4-Substituted-thiazol-2-yl) hydantoins as Anti-inflammatory and CNS-Active Agents", Pharmazie, vol. 38, pp. 341-342 (1983).
Woehrmann et al., "Local Skin Reactivity After Induction of Shwartzman Reaction in Rabbits", Exp. Toxic. Pathol., 47, pp. 167-172 (1995).
Cortes et al., "Effect of Structural Modification of the Hydantoin Ring on Anticonvulsant Activity", J. Med. Chem., 28, pp. 601-606 (1985).
Angew, Chem., vol. 73, p. 66 (1961).
Waser et al., "Die Entwicklung neuer Antiepiliptika", Arzneim. Forsch/Drug Res., 27(II), pp. 1942-1953 (1977).
Fischer et al., "Investigation of the Antitumor Activity of New Epoxide Derivatives", Arzneim. Forsch/Drug Res., 34 (I), pp. 663-668 (1984).

Affiliated with

Also associated with

Rating

Substituted 2, 4-imidazolidinedione compounds as pharmaceutical does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted 2, 4-imidazolidinedione compounds as pharmaceutical , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2, 4-imidazolidinedione compounds as pharmaceutical will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-505394